These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9652981)

  • 21. Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats.
    Sampey DB; Burrell LM; Widdop RE
    Am J Physiol; 1999 Mar; 276(3):R872-9. PubMed ID: 10070150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a nonpeptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis.
    Kurihara I; Saito T; Obara K; Shoji Y; Hirai M; Soma J; Sato H; Imai Y; Abe K
    Nephron; 1996; 73(4):629-36. PubMed ID: 8856262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
    Burrell LM; Phillips PA; Risvanis J; Aldred KL; Hutchins AM; Johnston CI
    Hypertension; 1995 Nov; 26(5):828-34. PubMed ID: 7591025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Ikeda T; Iwanaga Y; Watanabe H; Morooka H; Akahoshi Y; Fujiki H; Miyazaki S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):487-96. PubMed ID: 26248278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD; He G; Schiffrin EL
    Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic and selective vasopressin blockade in spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Yamamura Y; Saruta T
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1467-71. PubMed ID: 7810754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis.
    Fukui M; Nakamura T; Ebihara I; Nagaoka I; Tomino Y; Koide H
    J Lab Clin Med; 1993 Feb; 121(2):224-34. PubMed ID: 8094426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
    Fraser TB; Turner SW; Wen C; Li M; Burrell LM; Whitworth JA
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):866-70. PubMed ID: 11071300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function.
    Nakamura T; Sakamaki T; Kurashina T; Hoshino J; Sato K; Ono Z; Murata K
    Life Sci; 1994; 55(4):PL67-72. PubMed ID: 8028441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart.
    Sarzani R; Arnaldi G; Takasaki I; Brecher P; Chobanian AV
    Hypertension; 1991 Nov; 18(5 Suppl):III93-9. PubMed ID: 1657776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
    Okada H; Suzuki H; Kanno Y; Saruta T
    Clin Exp Hypertens; 1995 Apr; 17(3):469-83. PubMed ID: 7613523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
    Zhan Y; Kim S; Kawano H; Iwao H
    Hypertens Res; 2002 Mar; 25(2):295-301. PubMed ID: 12047046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nonpeptide and selective V1 and V2 antagonists on blood pressure short-term variability in spontaneously hypertensive rats.
    Japundzić-Zigon N; Milutinović S; Jovanović A
    J Pharmacol Sci; 2004 May; 95(1):47-55. PubMed ID: 15153650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?
    Gnudi L; Viberti G; Raij L; Rodriguez V; Burt D; Cortes P; Hartley B; Thomas S; Maestrini S; Gruden G
    Hypertension; 2003 Jul; 42(1):19-24. PubMed ID: 12771048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
    Okada H; Suzuki H; Kanno Y; Yamamura Y; Saruta T
    Clin Sci (Lond); 1994 Apr; 86(4):399-404. PubMed ID: 8168333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Betaxolol inhibits extracellular signal-regulated kinase and P70S6 kinase activities and gene expressions of platelet-derived growth factor A-chain and transforming growth factor-beta1 in Dahl salt-sensitive hypertensive rats.
    Kobayashi N; Nakano S; Mori Y; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
    Hypertens Res; 2002 Mar; 25(2):211-9. PubMed ID: 12047037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
    Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
    J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.
    Satoh C; Fukuda N; Hu WY; Nakayama M; Kishioka H; Kanmatsuse K
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):108-18. PubMed ID: 11152368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension.
    Dworkin LD; Tolbert E; Recht PA; Hersch JC; Feiner H; Levin RI
    Hypertension; 1996 Feb; 27(2):245-50. PubMed ID: 8567047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.